Baroreceptor afferent fibers synapse in the nucleus tractus solitarius (NTS) of the medulla. Neuronal cannabinoid (CB)1 receptors are expressed in the NTS and central administration of CB1 receptor agonists affect blood pressure (BP) and heart rate. In addition, there is evidence that endocannabinoids are produced in the brain stem. This study examined whether changes in CB1 receptor activity in the NTS modulated the baroreceptor reflex, contributing to changes seen in BP and heart rate. Baroreflexes were evoked in anesthetized dogs by pressure ramp stimulations of the isolated carotid sinus before and after microinjection of CB1 receptor agonist WIN-55212-2 (1.25-1.50 pmol) or antagonist SR-141716 (2.5-3.0 pmol) into cardiovascular regions of the NTS. Microinjection of the SR-141716 did not affect baseline BP or baroreflex sensitivity. However, SR-141716 significantly prolonged the time needed to return to the baseline level of BP after the pressure ramp. Microinjection of WIN-55212-2 had no effect on the baroreflex. These data suggest that endocannabinoids can modulate the excitability of NTS neurons involved in the baroreceptor reflex, leading to modulation of baroreflex regulation. endocannabinoids; sympathetic outflow; glutamate; SR-141716; WIN-55212-2 IT IS KNOWN THAT THE CANNABINOIDS (CBs) produce cardiovascular effects in vivo. For example, in anesthetized rats and dogs, ⌬ 9 -tetrahydrocannabinol (⌬ 9 -THC) produces a transient pressor response followed by longlasting hypotension and bradycardia (12,16,39). The hypotensive effect of ⌬ 9 -THC is mimicked by various CBs with a rank order of potency that strongly correlates with the affinity of these CBs for the neuronal CB 1 receptor (15). The administration of the endocannabinoid, N-arachidonylethanolamine (AEA; anandamide), produces a brief pressor response, followed by a prolonged decrease in blood pressure (BP) (37). The AEA-induced depressor response is inhibited by coadministration of the CB 1 receptor antagonist, SR-141716 (37), and is absent in CB 1 null mice (13).The hypothesis was made decades ago that the hypotensive and bradycardiac effects of the CBs resulted from an inhibition of sympathetic outflow (10, 40). For instance, the hypotensive effect of the synthetic CB, 1-hydroxy-3(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9, 10-tetrahydro-6-dibenzopyran (DMHP), was lost with spinal cord transections of the first cervical vertebra. Additionally, the administration of a low dose of DMHP to dogs resulted in a loss of the pressor reflex induced by common carotid artery occlusion. Because the pressor response to epinephrine was preserved in these animals, it was concluded that DMHP interrupted sympathetic innervation of blood vessels (10). Other researchers (40) arrived at the same conclusion and suggested that the site of CB action was at CNS cardioregulatory centers. In contrast, recent animal studies using AEA and the CB 1 receptor agonist WIN-55212-2 suggest that CBs also act at CNS cardioregulatory centers, and the result of these effects is enhan...